Loading organizations...
Loading organizations...
Regenerative medicine startup delivering therapies for bullous keratopathy.
Cellusion has raised $29.8M across 2 funding rounds.
Cellusion has raised $29.8M in total across 2 funding rounds.
Cellusion has raised $29.8M in total across 2 funding rounds.
Cellusion's investors include AIS CAPITAL, Axil Capital, DBJ Capital, Gemseki, Yoshiharu Asai, Nikon-SBI Innovation Fund, Junichi Imoto, SMBC Venture Capital, SPARX Asset Management, Hiroaki Kobayashi, Keio Innovation Initiative, Toho Holding.
Cellusion has raised $29.8M across 2 funding rounds. Most recently, it raised $20.3M Series C in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 7, 2023 | $20.3M Series C | AIS CAPITAL, Axil Capital, DBJ Capital, Gemseki, Yoshiharu Asai, Nikon-SBI Innovation Fund, Junichi Imoto, SMBC Venture Capital, SPARX Asset Management, Hiroaki Kobayashi | |
| Jan 7, 2022 | $9.5M Other Equity | DBJ Capital, Keio Innovation Initiative, SMBC Venture Capital | Gemseki, Toho Holding, Toyo Seikan, University of Tokyo Edge Capital |